AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Novel Vaccine Has Potent Anticancer Activity.(Brief Article)
2001 OCT 11 - (NewsRx.com & NewsRx.net) --
Biomira Inc. announced that its lead product candidate, Theratope vaccine, has been reviewed in the September 2001 issue of Ashley Publications' Expert Opinion on Biological Therapy, a United Kingdom bimonthly, peer-reviewed journal.
The authors of the paper are Drs. Leona A. Holmberg and Brenda M. Sandmaier. Holmberg and Sandmaier are clinical researchers at the Fred Hutchinson Cancer Research Center and professors of medicine at the University of Washington in Seattle.
The paper focuses on the concept that Theratope vaccine's synthetic carbohydrate antigen, Sialyl-Tn (STn), "is an ideal candidate for active specific immunotherapy (ASI)," and that, "ASI is a promising approach to treating cancer." The STn antigen is seen on many forms of human tumours.
The article outlines many of the trials conducted to date with Theratope vaccine. These include non-transplant clinical trials and clinical trials with Theratope vaccine after autologous stem cell transplant or stem cell rescue. The authors concluded, ...
- First patient enrolled in Theratope vaccine phase II trial.(breast cancer...
- Magazine article from: Women's Health Weekly October 31, 2002 700+ words
...clinical development of Theratope vaccine. Biomira and Merck...enrollment in a phase III Theratope vaccine clinical trial for...collaborator for Theratope vaccine is Merck KGaA, of...prepared by Women's Health Weekly editors from staff...
- Metastatic breast cancer vaccine trial to continue.(Theratope vaccine)
- Magazine article from: Women's Health Weekly November 28, 2002 700+ words
...metastatic breast cancer. Theratope vaccine has fast-track...the development of Theratope vaccine, reached this decision...strategy for moving Theratope vaccine forward in the metastatic...prepared by Women's Health Weekly editors from staff...
- Biomira Plans Interim Analysis Of Theratope Vaccine Data.(Brief Article)
- Magazine article from: Women's Health Weekly November 15, 2001 700+ words
...the end of 2003. Theratope vaccine has fast track designation...possible and position Theratope vaccine for a successful...continue to believe that Theratope vaccine is a great fit with...prepared by Women's Health Weekly editors from staff...
- Data from Theratope Vaccine trial presented.
- Magazine article from: Women's Health Weekly January 8, 2004 700+ words
...from the final analysis of their Theratope Vaccine phase III clinical trial in women...and survival in patients receiving Theratope vaccine and those on the KLH control arm...titres and to evaluate the impact of Theratope vaccine therapy on patients' health-related...
- Data from Theratope vaccine trial to be presented at breast cancer symposium.
- Magazine article from: Women's Health Weekly October 2, 2003 700+ words
...from the final analysis of its Theratope vaccine phase III clinical trial in...development and commercialization of Theratope vaccine. The company is hopeful that...article was prepared by Women's Health Weekly editors from staff and other...
- Theratope vaccine trial unblinded, didn't meet endpoints.
- Magazine article from: Women's Health Weekly July 24, 2003 700+ words
...reported on trial results from Biomira's phase III Theratope vaccine trial in metastatic breast cancer. The trial enrolled...completion. This article was prepared by Women's Health Weekly editors from staff and other reports.
- Phase III Theratope vaccine trial does not meet primary endpoints.
- Magazine article from: Women's Health Weekly July 17, 2003 700+ words
...the results from a large pivotal phase III trial of Theratope vaccine for women with metastatic breast cancer did not meet...McPherson. This article was prepared by Women's Health Weekly editors from staff and other reports.
- THERATOPE Vaccine to Enter Phase III Clinical Trials.
- Press release article from: Business Wire August 20, 1997 700+ words
...breast cancer who were treated with THERATOPE vaccine. The proposed double blind, prospectively...provide the evidence as to whether THERATOPE vaccine can delay disease progression and...patients randomized to treatment with THERATOPE vaccine and patients randomized to a placebo...
